US 11613527
Enzyme inhibitors
granted A61PA61P29/00
Quick answer
US patent 11613527 (Enzyme inhibitors) held by KalVista Pharmaceuticals Limited expires Mon Mar 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- KalVista Pharmaceuticals Limited
- Grant date
- Tue Mar 28 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 46
- CPC classes
- A61P, A61P29/00